# S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

> **NCT01224665** · NA · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 658 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **PROCEDURE:** therapeutic conventional surgery
- **PROCEDURE:** therapeutic standard lymphadenectomy
- **PROCEDURE:** therapeutic extended lymphadenectomy

## Key facts

- **NCT ID:** NCT01224665
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-25
- **Primary completion:** 2024-05
- **Final completion:** 2024-05
- **Target enrollment:** 658 (ACTUAL)
- **Last updated:** 2024-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01224665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01224665, "S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01224665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*